Evidence map›Paper›PMID 41132341›Full record

ArticleTranslational andrology and urology2025

Mechanistic study of

Liangliang Ben, Jian Wang, Peng Wu

Abstract read
In one paragraph

Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liangliang BenDepartment of Urology, Nantong Rehabilitation Hospital (Nantong Second People's Hospital), Nantong, China.
Jian WangDepartment of Urology, Nantong Rehabilitation Hospital (Nantong Second People's Hospital), Nantong, China.
Peng WuDepartment of Urology, Nantong Rehabilitation Hospital (Nantong Second People's Hospital), Nantong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bladder cancer is highly malignant, but specific biomarkers and molecular targets are lacking. The aim of this study was to screen bladder cancer progression-related differential genes based on those associated with tumor-node-metastasis (TNM) staging, and to validate them by Methods: Common genes were screened and prognostically analyzed by cross-analyzing differential genes in The Cancer Genome Atlas (TCGA) database for bladder cancer stages T1-2 and T3-4, N1 and N2, and M0 and M1. The functions were further identified by enrichment analysis, and the biological functions of the differential genes in bladder cancer were verified using Results: The shared gene polypeptide N-acetylgalactosaminyltransferase 16 ( Conclusions:

Indexed as

biomarkerBladder cancerN-acetylgalactosaminyltransferase 16 (GALNT16)tumor-node-metastasis (TNM)

Identifiers

PMID41132341
PMCPMC12541496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.